Walgreens Boots Alliance Inc. (WBA) Set to Announce Earnings on Thursday
Walgreens Boots Alliance Inc. (NASDAQ:WBA) is scheduled to post its Q416 quarterly earnings results on Thursday, October 20th. Analysts expect Walgreens Boots Alliance to post earnings of $0.99 per share and revenue of $29.11 billion for the quarter.
Walgreens Boots Alliance Inc. (NASDAQ:WBA) opened at 78.01 on Tuesday. Walgreens Boots Alliance Inc. has a one year low of $71.50 and a one year high of $95.74. The stock has a 50 day moving average price of $80.79 and a 200-day moving average price of $80.97. The stock has a market cap of $84.43 billion, a PE ratio of 26.96 and a beta of 1.01.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 17th will be issued a $0.375 dividend. The ex-dividend date of this dividend is Tuesday, November 15th. This represents a $1.50 annualized dividend and a dividend yield of 1.92%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 51.90%.
In other news, EVP Kathleen Wilson-Thompson sold 23,996 shares of the stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $85.00, for a total value of $2,039,660.00. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director William C. Foote sold 2,067 shares of the stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $81.35, for a total value of $168,150.45. Following the completion of the sale, the director now owns 26,690 shares in the company, valued at $2,171,231.50. The disclosure for this sale can be found here. Insiders own 21.10% of the company’s stock.
Hedge funds have recently made changes to their positions in the stock. Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of Walgreens Boots Alliance by 60.1% in the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 7,525,003 shares of the pharmacy operator’s stock valued at $626,607,000 after buying an additional 2,825,700 shares during the last quarter. Burgundy Asset Management Ltd. boosted its stake in Walgreens Boots Alliance by 20.3% in the second quarter. Burgundy Asset Management Ltd. now owns 5,292,069 shares of the pharmacy operator’s stock worth $440,671,000 after buying an additional 891,456 shares in the last quarter. Stifel Financial Corp acquired a new stake in Walgreens Boots Alliance during the second quarter worth $66,411,000. FIL Ltd boosted its stake in Walgreens Boots Alliance by 4,942.8% in the second quarter. FIL Ltd now owns 577,399 shares of the pharmacy operator’s stock worth $48,080,000 after buying an additional 565,949 shares in the last quarter. Finally, Parametric Portfolio Associates LLC boosted its stake in Walgreens Boots Alliance by 20.7% in the second quarter. Parametric Portfolio Associates LLC now owns 2,718,241 shares of the pharmacy operator’s stock worth $226,348,000 after buying an additional 466,466 shares in the last quarter. Institutional investors and hedge funds own 59.76% of the company’s stock.
A number of research firms recently weighed in on WBA. Deutsche Bank AG reaffirmed a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a report on Friday, September 9th. Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Tuesday, June 21st. Robert W. Baird reissued an “outperform” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Saturday, September 10th. Credit Suisse Group AG reissued a “buy” rating and set a $82.51 target price (down previously from $95.00) on shares of Walgreens Boots Alliance in a report on Monday, July 18th. Finally, Keefe, Bruyette & Woods reissued an “underperform” rating on shares of Walgreens Boots Alliance in a report on Friday, July 22nd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $93.35.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.